Deep phenotyping of the Cdhr1−/− mouse validates its use in pre-clinical studies for human CDHR1-associated retinal degeneration. (July 2021)

• Record Type: Journal Article
• Authors: Yusuf, Imran H.; McClements, Michelle E.; MacLaren, Robert E.; Charbel Issa, Peter
• Is Part Of: Experimental eye research. Volume 208(2021)
• Publication Date: 2021-07
• Subjects: CDHR1 -- Cadherin-related family member 1 -- Cone-rod dystrophy -- Retinitis pigmentosa -- Macular dystrophy -- Macular degeneration -- Optical coherence tomography -- Electroretinography -- Light toxicity; Ophthalmology -- Periodicals; Eye -- Periodicals; Œil -- Périodiques; Ophthalmology; Periodicals; Electronic journals; 612.8405
• DOI: 10.1016/j.exer.2021.108603
• Languages: English
• ISSNs: 0014-4835

Abstract

Abstract: Purpose: To validate the Cdhr1 −/− mouse as a model for human CDHR1 -associated retinal degeneration, which may present as cone-rod dystrophy or geographic atrophy. Methods: Deep phenotyping of Cdhr1 −/− (n = 56) and C57BL6J wildtype control mice (n = 45) was undertaken using in vivo multimodal retinal imaging and dark- and light-adapted electroretinography (ERG) over 15 months to evaluate rod- and cone-photoreceptor responses and retinal morphology. Results: Cdhr1 −/− retinas exhibited outer retinal thinning on optical coherence tomography (OCT) at 1-month versus C57BL6J (mean 14.6% reduction; P < 0.0001 ), with progressive degeneration to 15 months. The OCT layer representing photoreceptor outer segments was more significantly shortened in Cdhr1 −/− eyes at 1 month (mean 33.7% reduction; P < 0.0001 ), remained stable to 3 months and was not identifiable at later timepoints. Outer retinal thinning was more pronounced at inferior versus superior retinal locations in Cdhr1 −/− eyes ( P < 0.002 at 3–9 months). Dark-adapted ERG identified severe functional deficits in Cdhr1 −/− mice at 1 month of age versus C57BL6J (mean 62% reduction) that continued to decline to 15 months ( P < 0.0001 ). Light-adapted flicker identified severe deficits in cone function at 1 month (mean 70% reduction), with improved function to 3 months followed by progressive decline ( P < 0.0001 ). Conclusions: The Cdhr1 −/− mouse exhibits structural and functional evidence of progressive outer retinal degeneration at a slow rate. Early functional deficits affecting both rod and cone photoreceptors in the context of relatively mild structural changes reflect the human phenotype. This study validates the use of the Cdhr1 −/− mouse for the pre-clinical evaluation of therapeutics for human CDHR1 -associated retinal degeneration. Graphical abstract: Image 1 Highlights: Cdhr1 −/− mice recapitulate the phenotype of CDHR1 -associated cone-rod dystrophy. Severe rod and cone dysfunction is present in Cdhr1 −/− mice at 1-month of age. Shortening of photoreceptor outer segments explains early functional deficits. Progressive functional decline is attributable to gradual photoreceptor cell death. A wide therapeutic window is available in CDHR1 -associated cone-rod dystrophy.